Cosmos Health Inc.
Cosmos Health Inc. (COSM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cosm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cosmos Health Inc. (COSM) measures how much investors pay for each dollar of the company's trailing earnings. COSM's current PE ratio of N/A is calculated by dividing its stock price of $0.23 by its TTM earnings per share of -$0.45.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2009 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%82.5x
MedianQ3 · 75%527.8x
Max
At N/A, COSM's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cosmos Health Inc.You COSM | $14M | N/A | — | -$0.45 |
 CASI Pharmaceuticals, Inc. CASI | $2M | N/A | — | -$2.56 |
 Clearside Biomedical, Inc. CLSD | $2M | N/A | — | -$6.98 |
 Femasys Inc. FEMY | $19M | N/A | — | -$9.42 |
 Inspira Technologies Oxy B.H.N. Ltd. IINN | $45M | N/A | — | -$0.45 |
 Lisata Therapeutics, Inc. LSTA | $31M | N/A | — | -$1.91 |
 MetaVia Inc. MTVA | $4M | N/A | — | -$7.35 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.63 | — | |
2024-12-31 FY2024 | — | $-0.85 | — | |
2023-12-31 FY2023 | — | $-1.55 | — | |
2022-12-31 FY2022 | — | $-7.17 | — | |
2021-12-31 FY2021 | — | $-12.12 | — | |
2020-12-31 FY2020 | 82.45x | $1.55 | — | |
2019-12-31 FY2019 | — | $-6.21 | — | |
2018-12-31 FY2018 | — | $-17.02 | — | |
2017-12-31 FY2017 | — | $-12.25 | — | |
2016-12-31 FY2016 | — | $-1.25 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cosmos Health Inc. (COSM) measures how much investors pay for each dollar of the company's trailing earnings. COSM's current PE ratio of N/A is calculated by dividing its stock price of $0.23 by its TTM earnings per share of -$0.45.
Frequently asked questions
COSM pe ratio · 6 questionsCOSM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.23 and TTM EPS of -$0.45. Data sourced from Financial Modeling Prep via COSM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cosmos Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09